NovoCure Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NovoCure Limited generated cash of -$73,336,000, which is less than the previous year. Cash used in financing activities reached the amount of $15,787,000 last year. Net change in cash is therefore $126,730,000.
Cash Flow
| 2014 | -74.24M | -46.18M | 2.14M |
|---|---|---|---|
| 2015 | -99.88M | -115.29M | 276.98M |
| 2016 | -107.59M | 12.81M | 75.12M |
| 2017 | -33.13M | 6.77M | 5.16M |
| 2018 | -1.86M | -5.49M | 69.36M |
| 2019 | 26.62M | -51.66M | 61.68M |
| 2020 | 99.14M | -472.84M | 440.20M |
| 2021 | 82.75M | -144.83M | 25.70M |
| 2022 | 30.78M | -139.95M | 15.49M |
| 2023 | -73.33M | 184.14M | 15.78M |
NVCR Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 115.83M | 209.60M | 246.17M | 179.41M | 142.75M | 80.71M | 99.78M | 119.42M | 57.61M | 175.89M |
Operating activities | ||||||||||
Net income | -207.04M | -92.53M | -58.35M | 19.80M | -7.23M | -63.55M | -61.66M | -131.84M | -111.58M | -80.68M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 10.96M | 10.62M | 10.25M | 9.15M | 8.46M | 9.00M | 7.67M | 5.65M | 3.15M | 1.96M |
Stock-based compensation expense | 115.60M | 106.95M | 94.9M | 75.72M | 52.41M | 0 | 27.11M | 22.13M | 11.86M | 4.62M |
| Deferred income tax benefit | 115.60M | 106.95M | 94.9M | 75.72M | 52.41M | 0 | 27.11M | 22.13M | 11.86M | 4.62M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 29.41M | 2.54M | 5.27M | -30.35M | -36.49M | -4.15M | -23.22M | -6.33M | -1.30M | 1.17M |
Inventories | -8.91M | -4.34M | 2.48M | -2.93M | -1.15M | -529K | 3.52M | -11.95M | -10.14M | -1.55M |
Accounts payable | 14.86M | 14.25M | 27.77M | 25.47M | 16.88M | 9.50M | -1.15M | 1.60M | 6.96M | -492K |
Cash generated by operating activities | -73.33M | 30.78M | 82.75M | 99.14M | 26.62M | -1.86M | -33.13M | -107.59M | -99.88M | -74.24M |
Investing activities | ||||||||||
Purchases Of Investments | -1.00B | -1.29B | -1.07B | -607.87M | -461.84M | -253.78M | -104.00M | -239.34M | -208.99M | -137.98M |
Investments In Property Plant And Equipment | -27.09M | -21.35M | -24.17M | -14.96M | -10.48M | -6.71M | -7.36M | -17.66M | -10.27M | -2.31M |
Acquisitions Net | 0 | 118.59M | 120.66M | 457.87M | 41.18M | 3.79M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 184.14M | -139.95M | -144.83M | -472.84M | -51.66M | -5.49M | 6.77M | 12.81M | -115.29M | -46.18M |
Financing activities | ||||||||||
Common Stock Issued | 4.41M | 5.22M | 4.54M | 3.37M | 2.46M | 1.83M | 1.54M | 616K | 252.13M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | 0 |
Repayments of term debt | -10K | -28K | -26K | -150.02M | -31K | -100.08M | -57K | -70K | 22.82M | -63K |
Cash used in financing activities | 15.78M | 15.49M | 25.70M | 440.20M | 61.68M | 69.36M | 5.16M | 75.12M | 276.98M | 2.14M |
Net Change In Cash | 126.73M | -93.77M | -36.56M | 66.75M | 36.66M | 62.03M | -21.18M | -19.64M | 61.81M | -118.28M |
Cash at end of period | 242.56M | 115.83M | 209.60M | 246.17M | 179.41M | 142.75M | 78.59M | 99.78M | 119.42M | 57.61M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |